MPM BioImpact
Status
ACTIVE
Global HQ
California, United States
Countries of investment
- Israel
- USA
- Canada
Investment stages
- Seed
Industries
- Fintech
- Pharma
- Biotechnology
- Health Tech
- Medical Devices
About
MPM BioImpact is building companies to transform patient outcomes.
MPM BioImpact is building companies to transform patient outcomes.
Investment Thesis
They create and invest in biotech companies with innovative technologies that are developing lifesaving drugs for patients. They invest in both private and public companies, providing a unique longitudinal view of drug development across the industry.
Manager's Experience
Bringing a wealth of experience in private equity, the fund manager has successfully executed over 50 deals across various sectors, including technology, healthcare, and consumer products. Primarily focused on North America and Europe, they adopt a thematic investment approach, emphasizing data-driven decision-making. With a strong track record of notable exits, they prioritize growth-stage investments, ensuring alignment with operator-first strategies that enhance operational efficiencies. Their strategic style is characterized by a deep understanding of market dynamics and a commitment to value creation.
Team
William Greene
Todd Link
Todd Foley
Steven Peter
Sarah
Ryan Hersey
Patrick A. Baeuerle
Luke Evnin
Luke Evnin
Liz Doherty